(Thanks to Israel21c and Globes) Elelyso – a new treatment for Gaucher’s disease, from Israel’s Protalix BioTherapeutics, is set to hit pharmacies around the globe, following approval by the American Food and Drug Administration. The drug has been licensed to Pfizer.
http://israel21c.org/news/fda-approves-israeli-made-gaucher-drug-elelyso/?utm_source=rss&utm_medium=rss&utm_campaign=fda-approves-israeli-made-gaucher-drug-elelyso
http://www.globes.co.il/serveen/globes/docview.asp?did=1000745325&fid=1725